Hyperthermic intraperitoneal chemotherapy combined with cytoreductive procedure in patients with peritoneal pseudomyxoma

Gafton G.I.; Senchik K.Iu.; Kireeva G.S.; Petrov V.G.; Semiglazov V.V.; Guseynov K.D.; Bespalov V.G.; Beliaeva O.A.; Beliaev A.M.

doi:https://doi.org/10.17116/hirurgia2016526-30

Gafton G.I.

N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia

Senchik K.Iu.

Nauchno-issledovatel'skiĭ institut onkologii im. N.N. Petrova Minzdrava RF, Sankt-Peterburg

Kireeva G.S.

Nauchno-issledovatel'skiĭ institut onkologii im. N.N. Petrova Minzdrava RF, Sankt-Peterburg

Petrov V.G.

Kafedra FPK i PPS "Tiumenskaia gosudarstvennaia meditsinskaia akademiia";
GBUZ TO "Tiumenskaia oblastnaia klinicheskaia bol'nitsa #2"

Semiglazov V.V.

N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia

Guseynov K.D.

N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia

Bespalov V.G.

Nauchno-issledovatel'skiĭ institut onkologii im. N.N. Petrova Minzdrava RF, Sankt-Peterburg

Beliaeva O.A.

Moskovskiĭ nauchno-issledovatel'skiĭ institut pediatrii i detskoĭ khirurgii Minzdrava RF

Beliaev A.M.

NII onkologii im. N.N. Petrova Minzdravsotsrazvitiia Rossii;
Voenno-meditsinskaia akademiia im. S.M. Kirova, Sankt-Peterburg

Hyperthermic intraperitoneal chemotherapy combined with cytoreductive procedure in patients with peritoneal pseudomyxoma

Authors:

Gafton G.I., Senchik K.Iu., Kireeva G.S., Petrov V.G., Semiglazov V.V., Guseynov K.D., Bespalov V.G., Beliaeva O.A., Beliaev A.M.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2016;(5): 26‑30

DOI: 10.17116/hirurgia2016526-30

Read: 1272 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gafton GI, Senchik KIu, Kireeva GS, et al. . Hyperthermic intraperitoneal chemotherapy combined with cytoreductive procedure in patients with peritoneal pseudomyxoma. Pirogov Russian Journal of Surgery. 2016;(5):26‑30. (In Russ.)
https://doi.org/10.17116/hirurgia2016526-30

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Treatment of pseudomyxoma peritoneum. (A review of the literature and a clinical case). P.A. Herzen Journal of Oncology. 2025;(5):68-72

Abstract:

Aim. To study the results of intraperitoneal chemoperfusion combined with cytoreductive procedure in patients with peritoneal pseudomyxoma. Material and methods. For the period 2006-2015 seven patients with peritoneal pseudomyxoma underwent aggressive treatment using hyperthermic intraperitoneal chemoperfusion combined with cytoreductive procedure at the Department of General Oncology of N.N. Petrov Research Institute of Oncology. Results. Two patients had postoperative complications. One of them died after 12 days postoperatively. Features of postoperative complications were predominantly determined by volume of cytoreduction. Advanced tumoral process caused death in 2 patients additionally. Other patients are still alive during 4-28 months after surgery. Conclusion. Hyperthermic intraperitoneal chemoperfusion combined with cytoreductive procedure is advisable for peritoneal pseudomyxoma to improve survival. Optimal cytoreduction should be developed in researches with large number of patients to decrease incidence of complications.

Keywords:

peritoneal pseudomyxoma

cytoreductive procedure

hyperthermic intraperitoneal chemoperfusion

Authors:

Gafton G.I.

N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia

Senchik K.Iu.

Nauchno-issledovatel'skiĭ institut onkologii im. N.N. Petrova Minzdrava RF, Sankt-Peterburg

Kireeva G.S.

Nauchno-issledovatel'skiĭ institut onkologii im. N.N. Petrova Minzdrava RF, Sankt-Peterburg

Petrov V.G.

Kafedra FPK i PPS "Tiumenskaia gosudarstvennaia meditsinskaia akademiia";
GBUZ TO "Tiumenskaia oblastnaia klinicheskaia bol'nitsa #2"

Semiglazov V.V.

N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia

Guseynov K.D.

N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia

Bespalov V.G.

Nauchno-issledovatel'skiĭ institut onkologii im. N.N. Petrova Minzdrava RF, Sankt-Peterburg

Beliaeva O.A.

Moskovskiĭ nauchno-issledovatel'skiĭ institut pediatrii i detskoĭ khirurgii Minzdrava RF

Beliaev A.M.

NII onkologii im. N.N. Petrova Minzdravsotsrazvitiia Rossii;
Voenno-meditsinskaia akademiia im. S.M. Kirova, Sankt-Peterburg

Close metadata

References:

Аbdullaev А.G., Gorbunova V.А., Ter-Ovanesov M.D. i dr. TSitoreduktivnye vmeshatel'stva v sochetanii s gipertermicheskoj intraperitoneal'noj khimioperfuziej pri psevdomiksome [Cytoreductive interventions combined with intraperitoneal hyperthermic chemoperfusion for pseudomyxoma]. Opukholi zhenskoj reproduktivnoj sistemy. 2010;4:98-102. (In Russian)
Abu-Rustum NR, Barakat RR, Levine DA. Atlas of Procedures in Gynecologic Oncology. Third Edition. USA: CRC Press; 2013;472.
Austin F, Mavanur A, Sathaiah M et al. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol. 2012;19:1386-1393.
Baratti D, Kusamura S, Nonaka D et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15:526-534.
Bevan KE, Mohammed F, Moran BJ. Pseudomyxoma peritonei. World J Gastrointest Oncol. 2010;2:44-50.
Chua TC, Moran BJ, Sugarbaker PH et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449-2456.
Chua TC, Yan TD, Smigielski ME et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol. 2009;16:1903-1911.
El Halabi H, Gushchin V, Francis J et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19:110-114.
Elias D, Gilly F, Quenet F et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36:456-462.
Gonzalez-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91:304-311.
Hamilton T, Lanuke K, Mack LA, Temple WJ. Long-term follow-up in the treatment of peritoneal carcinomatosis. Am J Surg. 2011;201:650-654.
Haslinger MA, Francescutti V, Attwood K. Contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion. Cancer Med. 2013;2:334-342.
Honore C, Caruso F, Dartiques P et al. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix. Anticancer Res. 2015;35:4943-4947.
Ioannidis O, Cheva A, Paraskevas G et al. Pseudomyxoma retroperitonei: report of 2 cases and review of the literature. Rev Esp Enferm Dig. 2012;104:268-275.
McBride K, McFadden D, Osler T. Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis. J Surg Res. 2013;183:246-252.
Mohamed F, Cecil T, Moran B, Sugarbaker P. A new standard of care for the management of peritoneal surface malignancy. Curr Oncol. 2011;18:84-96.
Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104-109.
Spiliotis JD, Rogdakis A, Vaxevanidou A et al. Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Journal of BUON. 2009;14:259-264.
Stewart JHT, Shen P, Russell GB et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006;13:624-634.
Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol. 1998;14:254-261.
Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994;219:109-111.
Youssef H, Newman C, Chandrakumaran K et al. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum. 2011;54:293-299.